These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37711401)

  • 21. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT).
    Cillo U; Carraro A; Avolio AW; Cescon M; Di Benedetto F; Giannelli V; Magistri P; Nicolini D; Vivarelli M; Lanari J;
    Updates Surg; 2024 Jun; 76(3):725-741. PubMed ID: 38713396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in liver transplantation for hepatocellular carcinoma.
    Melloul E; Lesurtel M; Carr BI; Clavien PA
    Semin Oncol; 2012 Aug; 39(4):510-21. PubMed ID: 22846868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
    Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
    Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCC.
    Foerster F; Mittler J; Darstein F; Heise M; Marquardt JU; Wörns MA; Weinmann A; Sälter L; Hoppe-Lotichius M; Heinrich S; Kloeckner R; Pitton MB; Schattenberg JM; Sprinzl MF; Düber C; Otto G; Lang H; Galle PR; Zimmermann T
    Eur J Intern Med; 2018 Sep; 55():57-65. PubMed ID: 29859798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence.
    Vivarelli M; Risaliti A
    World J Gastroenterol; 2011 Nov; 17(43):4741-6. PubMed ID: 22147974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological differentiation predicts post-liver transplantation survival time.
    Li WX; Li Z; Gao PJ; Gao J; Zhu JY
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):201-8. PubMed ID: 24388339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver organ allocation for hepatocellular carcinoma: are we sure?
    Marsh JW; Dvorchik I
    Liver Transpl; 2003 Jul; 9(7):693-6. PubMed ID: 12827554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for hepatic tumors: a systematic review.
    Ravaioli M; Ercolani G; Neri F; Cescon M; Stacchini G; Del Gaudio M; Cucchetti A; Pinna AD
    World J Gastroenterol; 2014 May; 20(18):5345-52. PubMed ID: 24833864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.
    Salcedo M; Vinaixa C; Javle M; Trapero-Marugán M; Bustamante J; Line PD
    Transplantation; 2022 Jan; 106(1):e3-e11. PubMed ID: 34905758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term observation of hepatocellular carcinoma recurrence after liver transplantation at a European transplantation centre.
    Foerster F; Hoppe-Lotichius M; Vollmar J; Marquardt JU; Weinmann A; Wörns MA; Otto G; Zimmermann T; Galle PR
    United European Gastroenterol J; 2019 Jul; 7(6):838-849. PubMed ID: 31316788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma.
    Cheng JW; Shi YH; Fan J; Huang XW; Qiu SJ; Xiao YS; Wang Z; Dai Z; Tang ZY; Zhou J
    J Cancer Res Clin Oncol; 2011 Oct; 137(10):1445-53. PubMed ID: 21809031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.
    Schnitzbauer AA; Zuelke C; Graeb C; Rochon J; Bilbao I; Burra P; de Jong KP; Duvoux C; Kneteman NM; Adam R; Bechstein WO; Becker T; Beckebaum S; Chazouillères O; Cillo U; Colledan M; Fändrich F; Gugenheim J; Hauss JP; Heise M; Hidalgo E; Jamieson N; Königsrainer A; Lamby PE; Lerut JP; Mäkisalo H; Margreiter R; Mazzaferro V; Mutzbauer I; Otto G; Pageaux GP; Pinna AD; Pirenne J; Rizell M; Rossi G; Rostaing L; Roy A; Turrion VS; Schmidt J; Troisi RI; van Hoek B; Valente U; Wolf P; Wolters H; Mirza DF; Scholz T; Steininger R; Soderdahl G; Strasser SI; Jauch KW; Neuhaus P; Schlitt HJ; Geissler EK
    BMC Cancer; 2010 May; 10():190. PubMed ID: 20459775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation and hepatocellular carcinoma 2023: a narrative review of management and outcomes.
    Tabrizian P; Holzner ML; Zaret D; Meyerovich G; Fagenson A; Schiano T
    Ann Palliat Med; 2024 Jan; 13(1):126-140. PubMed ID: 38124475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Kim HR; Cheon SH; Rha SY; Lee S; Han KH; Chon CY; Lee JD; Sung JS; Chung HC
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):258-69. PubMed ID: 21884437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis.
    Cescon M; Bertuzzo VR; Ercolani G; Ravaioli M; Odaldi F; Pinna AD
    World J Gastroenterol; 2013 Dec; 19(48):9174-82. PubMed ID: 24409045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.